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Abstract
Purpose Low-grade inflammation and a diet high in salt are both established risk factors for cardiovascular disease. High 
potassium  (K+) intake was found to counter increase in blood pressure due to high salt intake and may potentially also have 
protective anti-inflammatory effects. To better understand these interactions under normal physiological conditions, we 
investigated the relationships between 22 inflammatory mediators with 24-h urinary  K+ in young healthy adults stratified by 
low, medium and high salt intake (salt tertiles). We stratified by ethnicity due to potential salt sensitivity in black populations.
Methods In 991 healthy black (N = 457) and white (N = 534) adults, aged 20–30 years, with complete data for 24-h urinary 
sodium and  K+, we analysed blood samples for 22 inflammatory mediators.
Results We found no differences in inflammatory mediators between low-, mid- and high-sodium tertiles in either the black 
or white groups. In multivariable-adjusted regression analyses in white adults, we found only in the lowest salt tertile that  K+ 
associated negatively with pro-inflammatory mediators, namely interferon gamma, interleukin (IL) -7, IL-12, IL-17A, IL-23 
and tumour necrosis factor alpha (all p ≤ 0.046). In the black population, we found no independent associations between  K+ 
and any inflammatory mediator.
Conclusion In healthy white adults, 24-h urinary  K+ associated independently and negatively with specific pro-inflammatory 
mediators, but only in those with a daily salt intake less than 6.31 g, suggesting  K+ to play a protective, anti-inflammatory 
role in a low-sodium environment. No similar associations were found in young healthy black adults.
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MIP-3α  Macrophage inflammatory protein 3-alpha
NF-κB  Nuclear factor kappa B
TNFα  Tumour necrosis factor alpha
Introduction
Inflammation is involved in the development of cardiovascular 
disease [1–3]. Additionally, a diet high in salt  (Na+) is another 
well-known risk factor for cardiovascular diseases, including 
hypertension [4]. It was recently reported that  Na+ intake mod-
ulates the release of pro-inflammatory mediators [5–7]. These 
two cardiovascular risk factors may, therefore, be mechanisti-
cally involved. Interstitial  Na+ rapidly achieves an equilibrium 
with plasma, and excess  Na+ is then excreted by the kidneys 
[8]. However, osmotically inactive  Na+ can also be stored in 
tissues, such as the skin, which in turn leads to changes in 
immune cell function and increased inflammation [9].
A diet high in potassium  (K+) intake was shown to counter 
the usual increase in blood pressure in response to high salt 
intake [10, 11]. This finding suggests that a high  K+ intake 
may have protective cardiovascular effects [12, 13]. As inflam-
mation and a diet high in  Na+ and low in  K+ may be additive 
risk factors for the development of cardiovascular disease, 
a better understanding is required to establish the potential 
impact of  K+ on cardiovascular health. As high  K+ intake has 
a beneficial effect on blood pressure [14], as well as cardiovas-
cular events and mortality [13], an additional mechanism of 
 K+ may be its anti-inflammatory properties [15]. This notion 
is supported by a study indicating that  K+ supplementation 
inhibited interleukin (IL) -17A production in human T lym-
phocytes that were induced by a salt load [5]. However, there 
is limited evidence on the role of  K+ in the regulation of other 
inflammatory mediators, such as C-reactive protein (CRP), 
IL-6, and IL-23.
When examining  Na+ and  K+ handling, an essential fac-
tor to account for is black ethnicity. Black individuals have 
higher levels of sodium retention than their white counterparts 
[16]. Previous studies also reported a greater proportion of 
salt sensitivity in black populations [16]. The cardiovascular 
risk in black populations may be further increased based on 
their more pro-inflammatory profile when compared to white 
adults [17].
To better understand these potential mechanisms involved 
in the development of cardiovascular disease, we performed a 
hypothesis-generating work by investigating whether a detailed 
range of 22 pro- and anti-inflammatory mediators are associ-
ated with 24-h urinary  K+ in young black and white adults. 
We specifically focussed on those with low, medium and high 
salt intake.
Methodology
Study population
This study forms part of the African prospective study 
on the early detection and identification of cardiovascu-
lar disease and hypertension (African-PREDICT) [18]. 
We recruited young black and white men and women, 
between the ages of 20 and 30 years. African-PREDICT 
included apparently healthy individuals who were HIV-
uninfected; had a screening office brachial blood pressure 
of < 140 mmHg systolic and < 90 mmHg diastolic; had no 
self-reported previous diagnosis or used any medication 
for a chronic disease; and, if female, were not currently 
pregnant or lactating. We analysed data of participants 
who were included in the baseline phase of the African-
PREDICT study (n = 1202). This study is a sub-cohort of 
a previously published larger cohort [17]. Participants on 
anti-inflammatory medication and with missing biochemi-
cal data  (Na+,  K+, and multiple inflammatory mediators) 
were additionally excluded resulting in a total of 991 par-
ticipants. The exclusion of individuals with missing urine 
data  (Na+ and  K+) allowed for investigation of a more 
specific research question.
Questionnaires, anthropometry and physical 
activity measurements
Self-reported data with regard to demographic and life-
style information were collected using a questionnaire. A 
24-h dietary recall questionnaire was administered by a 
trained dietitian or nutritionist on the study day and on two 
subsequent days. The average daily energy intake was then 
calculated. Socio-economic status was calculated using a 
point system that was adapted from Kuppuswamy’s Socio-
economic Status Scale [19] for a South African environ-
ment. Height, weight and waist circumference were meas-
ured using standard methods [18]. Body mass index (BMI) 
was calculated using weight (kg)/height (m)2. A compact, 
chest-worn accelerometric device (Actiheart4 CamNtech 
Ltd and CamNtech Inc, UK) was used to objectively meas-
ure physical activity over a maximum period of 7 days.
Ambulatory blood pressure
Participants were also fitted with a validated 24-h bra-
chial ambulatory blood pressure monitor (Card(X)plore® 
CE120, Meditech, Budapest, Hungary). The apparatus 
was programmed to record every 30 min during the day 
(06h00 to 22h00) and every hour during the night (22h00 
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to 06h00) [20]. Participants had a mean successful record-
ing rate of 88%.
24‑h urine collection
Participants were instructed to collect a 24-h urine sam-
ple on a day that was convenient for them and the date was 
noted. The first urine of the day was to be discarded and 
entire urine passed thereafter was collected in the provided 
container, including the first urine of the following morning 
(day 2). The start and finish time were recorded. The pro-
tocol for 24-h urine collection followed the Pan American 
Health Organisation/World Health Organisation (PAHO/
WHO) protocol for population-level  Na+ determination in 
24-h urine samples [21]. Incomplete urine collections were 
defined as a volume less than 300 mL per 24 h and/or a 24-h 
creatinine excretion of < 4 mmol or > 25 mmol in women 
and < 6 mmol or > 30 mmol in men [22].
Biological sampling and biochemical analyses
Participants fasted overnight for at least 8 h prior to attend-
ing the day of research measurements. Blood samples were 
collected from the median cubital vein. The samples were 
prepared according to the standardised protocol of the Afri-
can-PREDICT study and stored at − 80 °C until analysis 
[18].
Urinary  Na+,  K+ and chloride were measured by means of 
ion-selective electrode potentiometry on the Cobas  Integra® 
400 plus (Roche, Basel, Switzerland), and creatinine con-
centrations were measured using the Creatinine Jaffé Gen.2 
reagent (Roche, Basel, Switzerland). Daily urinary  Na+ and 
 K+ excretion (mmol/day) were calculated by multiplying the 
 Na+,  K+ and creatinine concentrations (mmol/L) of the 24-h 
urine by the total 24-h volume of urine (in litres). Daily salt 
intake was estimated from the 24-h urinary  Na+ excretion 
by converting  Na+ in mmol to mg:  Na+ (mmol) × 23 = Na+ 
(mg) [23] and then applying the conversion: 1  g salt 
(NaCl) = 390 mg  Na+ [23].
A MILLIPEX Map Human High Sensitivity T-Cell 
Magnetic Bead Panel (EMD Millipore, Merck, MO, USA) 
was used to analyse 21 cytokines. This multiplex panel was 
analysed using Luminex xMAP technology on the Luminex 
200™ analyser.
Serum samples were analysed for high-sensitivity CRP, 
total cholesterol, low- and high-density lipoprotein cho-
lesterol, glucose and γ-glutamyltransferase (GGT) (Cobas 
 Integra® 400plus, Roche, Basel, Switzerland). Serum cre-
atinine concentrations were measured using the Creatinine 
Jaffé Gen.2 reagent (Roche, Basel, Switzerland). Estimated 
creatinine clearance was determined using the Cock-
roft–Gault formula (Men [(140 − age) × weight in kg × 
1.23]/serum creatinine or women [(140 − age) × weight in 
kg × 1.04]/serum creatinine). Estimated glomerular filtra-
tion rate (eGFR) was calculated using the Chronic Kidney 
Disease-Epidemiology (CKD-EPI) formula, without race in 
the equation, as the correction for race is not suggested for a 
South African population [24, 25]. Serum cotinine was ana-
lysed using a chemiluminescence method on the Immulite 
(Siemens, Erlangen, Germany) apparatus.
Statistical analyses
IBM®,  SPSS® version 24 (IBM Corporation, Armonk, New 
York) was used for data analysis. GraphPad Prism 5.03 
(GraphPad Software, San Diego) was used to develop all 
graphs. Continuous variables were inspected for normal-
ity using Q–Q plots as well as inspection of skewness and 
kurtosis. Variables with non-Gaussian distributions were 
logarithmically transformed. To substantiate the analyses 
by ethnicity, we investigated the interactions of ethnicity 
on the relationship between  Na+,  K+ and the full range of 
pro- and anti-inflammatory mediators. Based on the interac-
tions, we divided our groups by ethnicity (Online Resource 
Table S1). Pro- to anti-inflammatory ratios were calculated 
based on the literatures [26, 27], and new ratios were sug-
gested based on instances where pro-inflammatory media-
tors were higher and anti-inflammatory mediators were 
lower in the black and white groups. T test and Chi-square 
test were used to compare the profiles of black and white 
participants. We further divided our groups by  Na+ tertiles, 
reflecting low, medium and high salt intake. Partial correla-
tions and backward stepwise multiple regression were used 
to determine the relationship between  K+ and pro- and anti-
inflammatory mediators. Partial correlations were adjusted 
for age, sex and waist circumference. Variables included in 
backward stepwise multiple regression models were:  K+, 
age, socio-economic status, AEE, waist circumference, total 
cholesterol, eGFR, cotinine, GGT, glucose and sex. In sensi-
tivity analyses, we also determined whether components of 
the renin–angiotensin–aldosterone system contribute to the 
model. Multiple regression analyses displayed the last model 
in which potassium remained.
Results
The general characteristics of the participants (n = 991) are 
shown in Table 1. The black and white groups were similar 
in age (24.5 years; p = 0.92) with an equal distribution in sex 
(p = 0.71). When viewing the detailed inflammatory media-
tor profile of the two groups, the black group had higher 
pro-to-anti-inflammatory ratios than their white counterparts 
(p ≤ 0.021) as was seen in a previous study in this popula-
tion [17].
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Table 1  Characteristics of 
young black and white adults
Black (n = 457) White (n = 534) p
Age, years 24.5 ± 3.12 24.5 ± 3.04 0.94
Male, n (%) 227 (49.7) 259 (48.5) 0.71
Socio-economic Status
 Low, n (%) 264 (57.8) 109 (20.4) < 0.001
 Middle, n (%) 123 (26.9) 163 (30.5)
 High, n (%) 70 (15.3) 262 (49.1)
Body composition
 Body mass index (kg/m2) 24.2 (17.8; 36.2) 25.0 (18.9; 35.1) 0.014
 Waist circumference (cm) 77.6 (63.5; 98.5) 81.5 (64.9; 107) < 0.001
24-h urine analysis
 Na+ (mmol/day) 134 (44.5; 353) 130 (45.5; 294) 0.47
 Salt (NaCl g/day) 7.88 (2.62; 20.8) 7.67 (2.68; 17.3) 0.47
 Above 5 g salt/day, n (%) 364 (79.6) 431 (80.7) 0.68
 K+ (mmol/day) 34.5 (12.7; 98.6) 49.7 (22.3; 107) < 0.001
 Below 90 mmol/day  K+, n (%) 441 (94.3) 460 (88.3) 0.001
 Na+/K+ 3.94 (1.93; 7.85) 2.59 (1.09; 5.37) < 0.001
Inflammatory markers
 Pro-inflammatory
  CRP (mg/L) 1.02 (0.10; 12.0) 0.75 (0.08; 7.13) 0.001
  Fractalkine (pg/mL) 28.1 (10.3; 74.4) 29.7 (10.8; 74.3) 0.15
  IFN-γ (pg/mL) 6.84 (1.65; 22.0) 7.83 (1.61; 22.2) 0.012
  IL-1β (pg/mL) 0.98 (021; 3.72) 1.10 (0.27; 3.70) 0.031
  IL-2 (pg/mL) 0.76 (0.13; 3.88) 0.84 (0.16; 3.95) 0.16
  IL-7 (pg/mL) 5.71 (1.37; 19.3) 5.63 (1.16; 18.6) 0.80
  IL-8 (pg/mL) 1.75 (0.44; 6.91) 1.88 (0.47; 8.11) 0.16
  IL-12 (pg/mL) 1.74 (0.36; 6.51) 1.97 (0.45; 6.72) 0.027
  IL-17 A (pg/mL) 3.18 (0.64; 14.2) 3.53 (0.64; 14.1) 0.088
  IL-23 (pg/mL) 118 (14.6; 609) 134 (12.9; 668) 0.10
  ITAC (pg/mL) 4.77 (1.50; 18.0) 3.64 (1.40; 11.5) < 0.001
  MIP-1α (pg/mL) 9.84 (2.98; 28.4) 10.3 (2.86; 27.4) 0.34
  MIP-1β (pg/mL) 7.21 (2.87; 15.7) 7.28 (2.93; 16.4) 0.76
  MIP-3α (pg/mL) 2.13 (0.56; 7.68) 1.87 (0.48; 5.77) 0.015
  TNF-α (pg/mL) 1.60 (0.42; 5.29) 1.79 (0.49; 5.76) 0.024
 Anti-inflammatory
  IL-4 (pg/mL) 44.2 (7.97; 166) 44.6 (8.29; 154) 0.88
  IL-5 (pg/mL) 0.89 (0.22; 3.90) 1.01 (0.26; 4.03) 0.025
  IL-10 (pg/mL) 4.37 (0.94; 20.2) 5.38 (1.13; 21.2) < 0.001
  IL-13 (pg/mL) 3.89 (0.58; 23.3) 4.98 (0.67; 31.4) 0.001
 Pro- and anti-inflammatory
  IL-6 (pg/mL) 1.87 (0.25; 10.3) 2.34 (0.31; 13.2) 0.002
  IL-21 (pg/mL) 1.31 (0.21; 6.05) 1.47 (0.26; 6.47) 0.088
  GM-CSF (pg/mL) 7.34 (1.19; 32.6) 8.59 (1.23; 38.0) 0.020
 Pro-to-anti inflammatory ratios
  IL-6/IL-10 0.29 (0.04; 2.62) 0.16 (0.03; 1.22) < 0.001
  IL-1β/IL-10 0.22 (0.08; 0.73) 0.20 (0.07; 0.52) 0.021
  TNF-α/IL-10 0.37 (0.16; 0.97) 0.34 (0.15; 1.01) 0.005
  CRP/IL-10 0.23 (0.01; 4.63) 0.14 (0.01; 2.36) < 0.001
  MIP-1α/IL-10 2.20 (0.72; 7.04) 1.84 (0.61; 5.90) < 0.001
  ITAC/IL-4 0.11 (0.02; 0.82) 0.08 (0.02; 0.67) < 0.001
  ITAC/IL- 5 5.42 (1.16; 29.4) 3.61 (0.78; 18.1) < 0.001
  ITAC/IL-10 1.10 (0.29; 6.78) 0.68 (0.22; 3.05) < 0.001
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There were no ethnic differences for  Na+ excretion 
(p = 0.47), but black participants had lower urine levels of 
 K+, with 94% black and 88% white participants having  K+ 
levels below recommended levels [28]. Black participants 
had higher  Na+/K+ ratios (p < 0.001) than the white group.
We determined the differences in inflammatory mediator 
concentrations according to  Na+ tertiles (Online Resource 
Table S2). For all inflammatory mediators, there were gener-
ally no differences.
To establish whether a relationship exists between  Na+ 
or  K+ with inflammatory mediators, we performed partially 
adjusted regression analyses in the total group as well as 
black and white groups separately (adjusted for age, sex and 
waist circumference as well as ethnicity in the total group) 
(Online Resource Table S3). These analyses yielded minimal 
correlations mostly with  K+ as indicated in detail in Online 
Resource Table S3.
Due to previous reports indicating the importance of  Na+/
K+ balance [29], we then performed partial correlations 
between  K+ and inflammatory mediators in the groups strati-
fied by  Na+ tertiles. In whites, we found several prominent 
results in the lowest  Na+ tertile (T1). These include posi-
tive correlations between  K+ and both interferon-inducible 
T-cell alpha chemoattractant (ITAC)/IL-5 and ITAC/IL-10. 
In T1, we also found negative correlations between  K+ and 
interferon gamma (IFN-γ), IL-1β, IL-5, IL-6, IL-7, IL-8, 
IL-12, IL-17A, IL-21, IL-23, macrophage inflammatory 
protein 3-alpha (MIP-3α) and tumour necrosis factor alpha 
(TNF-α). Additionally, in the middle tertile (T2),  K+ cor-
related inversely with IL-4 (Online Resource Fig. S1). In 
Bold values indicate p < 0.05. Data presented as mean ± SD; or geometric mean 95 CI. Granulocyte–
macrophage colony-stimulating factor (GM-CSF), interferon gamma (IFN-γ), interleukin 1 beta (IL-1β), 
interleukin 2 (IL-2), Interleukin 4 (IL-4), interleukin 5 (IL-5), interleukin 6 (IL-6), interleukin 7 (IL-7), 
interleukin 8 (IL-8), interleukin 10 (IL-10), interleukin 12 (IL-12), interleukin 13 (IL-13), interleukin 17A 
(IL-17A), interleukin 21 (IL-21), interleukin 23 (IL-23), interferon-inducible T-cell alpha chemoattract-
ant (ITAC), macrophage inflammatory protein 1-alpha (MIP-1α), macrophage inflammatory protein 1-beta 
(MIP-1β), Macrophage inflammatory protein 3-alpha (MIP-3α) and tumour necrosis factor alpha (TNFα), 
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; HDL-C high density 
lipoprotein cholesterol; LDL-C, low density lipoprotein chole sterol
Table 1  (continued) Black (n = 457) White (n = 534) p
  ITAC/IL-13 1.24 (0.18; 9.64) 0.73 (0.10; 5.90) < 0.001
Biochemical markers
 Total cholesterol (mmol/L) 3.49 ± 0.98 3.98 ± 1.31 < 0.001
 HDL-C (mmol/L) 1.14 ± 0.38 1.16 ± 0.45 0.58
 LDL-C (mmol/L) 2.09 (1.01; 3.82) 2.42 (1.18; 4.39) < 0.001
 Triglycerides (mmol/L) 0.63 (0.31; 1.35) 0.79 (0.33; 2.05) < 0.001
 Glucose (mmol/L) 3.91 ± 1.05 4.23 ± 1.11 < 0.001
 eGFR (mL/min/1.73m2) 123 ± 16.8 117 ± 20.3 < 0.001
 Estimated creatinine clearance (mL/min) 138 (87.0; 235) 147 (88.7; 262) 0.001
 Creatinine clearance (mL/min) 123 (56.4; 281) 128 (52.8; 311) 0.28
 Plasma renin activity surrogate 63.2 (11.3; 267) 127 (38.8; 346) < 0.001
 Angiotensin II (pg/mL) 47.6 (8.51; 197) 94.2 (29.3; 257) < 0.001
 Aldosterone (pg/mL) 24.7 (5.00; 96.5) 52.3 (10.1; 223) < 0.001
Ambulatory BP (mmHg)
 24 h SBP 116 ± 8.86 118 ± 9.94 < 0.001
 24 h DBP 68.7 ± 5.73 68.5 ± 5.85 0.62
Health behaviours
 Serum cotinine (ng/mL) 3.66 (1.00; 349) 3.13 (1.00; 306) 0.27
 Self-reported tobacco use, n (%) 110 (24.1) 116 (21.7) 0.37
 γ-glutamyltransferase (U/L) 22.0 (8.62; 66.4) 14.7 (5.40; 48.3) < 0.001
 Self-reported alcohol use, n (%) 236 (52.4) 292 (54.8) 0.46
 Hormonal contraceptive use, n (% of women) 105 (46.5) 112 (41.0) 0.22
Energy expenditure
 TEE (kcal/day) 2218 ± 394 2355 ± 497 < 0.001
 AEE (kcal/day) 430 ± 219 406 ± 204 0.12
Reported energy intake
 Energy intake (kcal/day) 2097 ± 806 2083 ± 710 0.82
 European Journal of Nutrition
1 3
fully adjusted regression analyses (Fig. 1), these findings 
were confirmed where  K+ associated negatively with the 
pro-inflammatory mediators IFN-γ, IL-7, IL-12, IL-17A, 
IL-23 and TNF-α, but only in the lowest  Na+ tertile T1 (all 
p ≤ 0.046).
In the black population, with partial correlations, we 
found in the highest  Na+ tertile (T3) positive correla-
tions between  K+ and both ITAC and IL-5, and negative 
correlations in the lowest tertile (T1) with ITAC/IL-4 
and ITAC/IL-5 (all p ≤ 0.046) (Online Resource Fig. S2). 
However, these results lost significance in fully adjusted 
regression analyses (Fig. 2). We examined renin, angioten-
sin II and aldosterone’s impact on the model, all of which 
exhibited no effect (results not shown). We additionally 
examined the relationship between  Na+ and inflamma-
tory mediators, stratified by  Na+, but found no significant 
correlations.
Fig. 1  Multi-variable adjusted regression analyses showing the rela-
tionship between inflammatory mediators and  K+ within each  Na+ 
tertile in white adults. Each model was adjusted for: age, sex, socio-
economic status, waist circumference, total cholesterol, glucose, 
gamma glutamyltransferase, cotinine, estimated glomerular filtration 
rate, activity energy expenditure. #p < 0.05
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Discussion
Low-grade systemic inflammation and  Na+ are both risk fac-
tors for the development of cardiovascular disease [1–4]. 
It has been suggested that  K+ may provide a protective 
anti-inflammatory effect [15]. Therefore, to better under-
stand the possible mechanisms through which a high-salt 
environment may predispose one to higher cardiovascular 
disease risk (potentially due to the loss of the ‘protective’ 
anti-inflammatory role of  K+), we examined the relation-
ships between a detailed range of inflammatory mediators 
and 24-h urinary  K+, in those with low, medium and high 
salt intake. When we stratified 991 young healthy black and 
white participants by  Na+ excretion tertiles, we found nega-
tive independent relationships between urinary  K+ and six 
pro-inflammatory mediators IFN-γ, IL-7, IL-12, IL-17A, 
IL-23 and TNF-α, but only in white adults and only in those 
within the lowest  Na+ tertile (with an equivalent of 4.21 
Fig. 2  Multi-variable adjusted regression analyses showing the rela-
tionship between inflammatory mediators and  K+ within each  Na+ 
tertile in black adults. Each model was adjusted for: age sex, socio-
economic status, waist circumference, total cholesterol, glucose, 
gamma glutamyltransferase, cotinine, estimated glomerular filtration 
rate, activity energy expenditure. #p < 0.05
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[0.63–6.31] g salt intake/day). These findings suggest that 
 K+ may exert protective anti-inflammatory functions, but 
only in individuals with a low salt intake as reflected by the 
24-h urinary  Na+ excretion.
Previous studies have shown that a diet high in  Na+ stim-
ulates an inflammatory response [6, 8, 30]. In healthy human 
participants participating in the Mars520 study, Titze et al. 
found an increase in the pro-inflammatory mediators IL-6 
and IL-23, as well as a decrease in the anti-inflammatory 
mediator IL-10 in those on a high-salt diet [7].
In support of our findings of several negative relation-
ships between pro-inflammatory mediators and urinary 
 K+, it was found that rats on a  K+-supplemented diet had 
suppressed renal inflammation [15]. This was evident by a 
decrease in macrophage infiltration and nuclear factor kappa 
B (NF-κB), as well as a lower expression of cytokines [15]. 
In addition, a study involving healthy humans found  K+ sup-
plementation to have an inhibiting effect on the production 
of IL-17A by T lymphocytes induced by salt loading [5]. 
One potential mechanism through which  K+ may suppress 
inflammation is via its anti-oxidant effect [5]. Increase in 
extracellular  K+ leads to elevated membrane-Na+ pump 
activity [31]. This in turn results in hyperpolarization and 
ultimately a reduction in oxidase activity [31]. A second 
proposed mechanism is via  K+ inhibiting the effects of  Na+ 
on mitogen-activated protein kinase p38 which, when acti-
vated, leads to an immune response [5]. It has also been sug-
gested that  K+ may suppress the activation of NF-κB, which 
is involved in regulating genes relating to inflammation in 
the kidneys [15, 32, 33].
When we examined the relationship between  K+ and 
inflammation, inverse relationships were seen with pro-
inflammatory mediators, but not with anti-inflammatory 
mediators. This suggests a potential role of  K+ in pro-
inflammatory processes. What is of particular interest is 
that this protective association is only seen in the lowest 
 Na+ tertile, with an average salt intake of 4.21 (0.63–6.31) 
g/day (or 10.7–107 mmol  Na+/day). The mean intake for 
the second and third  Na+ tertiles in the white group were 
8.13 (6.31–10.0) g salt/day and 13.9 (10.0–50.1) g salt/day, 
respectively. These findings suggest that once  Na+ intake 
exceeds the levels of the first  Na+ tertile, or when the  Na+/
K+ equilibrium becomes significantly imbalanced, the pro-
tective effect of  K+ may be lost. This may imply that while 
it is important to maintain an acceptable  Na+/K+ ratio, it is 
also of importance to do so at the recommended levels. Our 
findings, thus, suggest a loss of mediation of pro-inflam-
matory mediators by  K+ in individuals with increased  Na+ 
intake.
As previously mentioned, it is also important to consider 
the role of ethnicity on the relationship between inflam-
matory mediators,  K+ and  Na+. While numerous studies 
have examined differences in inflammation between ethnic 
groups, global findings remain contradictory [34]. However, 
multiple studies performed in South African populations 
have found that black individuals display higher levels of 
pro-inflammatory markers and an overall more pro-inflam-
matory profile [17, 35–37]. When examining  Na+, previ-
ous studies found that black adults have a predisposition for 
higher  Na+ retention [16]. Based on previous reports, look-
ing at salt sensitivity, black populations also have a greater 
response in blood pressure to  Na+ [38]. Regardless, research 
into the role of  Na+ and  K+ in inflammation in any popula-
tions, but particularly black populations, is limited. While 
some studies have, to a limited extent, examined the role of 
 K+ in inflammation [5, 15], to the best of our knowledge, 
none have examined this relationship stratified by ethnicity. 
This is of importance as studies have found ethnic differ-
ences in  K+ excretion, with black populations being found 
to excrete less  K+ than their white counterparts even when 
intake is matched [39].
Our findings were only present in the white group. 
Although, a previous study found that  K+ supplementa-
tion protects against an increase in blood pressure in black 
populations in response to a salt load [10]. In our study 
with the focus on inflammation, this potentially protective 
effect on blood pressure was not seen in terms of potential 
anti-inflammatory effects. It is unknown whether this lack 
of association in the black group may be due to the effects 
of salt sensitivity. It should, however, be taken into account 
that the black group had particularly low urinary  K+ levels. 
Only 6% of the black population had a  K+ intake above the 
recommended minimum of 90 mmol/day [28], which may be 
a reason for the lack of association in this group. While pro-
tective associations are seen in the white adults, their mean 
 K+ intake was also below the recommended daily  K+ intake, 
albeit to a lesser extent than the black population. It would 
certainly be worth investigating whether an increase in  K+ 
intake in both groups would result in greater anti-inflam-
matory responses. However, it is important to note that an 
increase in  K+ levels should not be achieved by increasing 
calorie intake, but rather through the consumption of foods 
high in  K+, such as fruits and vegetables [40].
A strength of our study is the absence of pre-existing 
chronic diseases, which gave us the opportunity to test our 
hypotheses in adults without an influence from pathology. 
Additionally, our study included a large panel of pro- and 
anti-inflammatory mediators which were analysed with a 
high-sensitivity kit. Although we included the renin–angio-
tensin–aldosterone system components in regression models, 
which yielded no contributory findings, the renin–angioten-
sin–aldosterone system is likely to be very important per-
haps in those who have developed hypertension. In terms 
of limitations, the use of a single collection of 24‐h urine 
does not account for day‐to‐day variations in  Na+ and  K+ 
excretion.
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In conclusion, in young apparently healthy white adults, 
we found significant negative relationships between 24-h 
urinary  K+ and specific pro-inflammatory mediators, but 
only in those with a daily salt intake of less than 6.31 g. Our 
results suggest that  K+ may play a protective, anti-inflam-
matory role in a low-sodium environment.
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